Literature DB >> 22294473

C reactive protein: impact on peripheral tissue oxygenation and perfusion in neonates.

Gerhard Pichler1, Mirjam Pocivalnik, Regina Riedl, Elisabeth Pichler-Stachl, Heinz Zotter, Wilhelm Müller, Berndt Urlesberger.   

Abstract

OBJECTIVE: C reactive protein (CRP) is a sensitive marker of acute inflammation of infectious and non-infectious origin. Aim was to use near-infrared spectroscopy (NIRS) to analyse peripheral oxygenation and perfusion in term and preterm neonates with elevated CRP levels, at a time when routine haemodynamic variables are still normal.
DESIGN: Prospective observational study. SETTINGS: Peripheral-muscle NIRS was performed in the first week of life. Tissue-oxygenation index (TOI), mixed venous oxygenation (SvO(2)), fractional oxygen extraction (FOE), haemoglobin flow (Hbflow), oxygen delivery (DO(2)) and oxygen consumption (VO(2)) were assessed. Blood samples were taken within 3 h of the NIRS measurements. PATIENTS: Cardiocirculatory stable term and preterm neonates with infection-related and infection-unrelated CRP elevations >10 mg/l were compared with neonates without CRP elevation. The two groups were matched for gestational and postnatal age.
RESULTS: 33 neonates with CRP elevation (gestational age 37.7±2.9 weeks) were compared with 33 controls (gestational age 37.3±2.9 weeks). In neonates with CRP elevation, TOI (68.9±6.6%), SvO(2) (66.9±7.3%) DO(2) (39.2±16.1 µmol/100ml/min) and VO(2) (10.9±3.4 µmol/100ml/min) were significantly lower compared with controls (TOI 72.9±3.8%, SvO(2) 70.2±4.7%, DO(2) 48.8±18.4 µmol/100ml/min, VO(2) 12.3±3.8 µmol/100ml/min). There was no significant difference in any other NIRS or routine haemodynamic parameter between the two groups.
CONCLUSION: Inflammatory processes with CRP elevation cause impaired peripheral oxygenation and perfusion in neonates even when routine haemodynamic variables are still normal. NIRS might offer a new non-invasive tool for the early recognition and diagnosis of infectious and non-infectious inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22294473     DOI: 10.1136/archdischild-2011-300578

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  5 in total

1.  Subcutaneous and Intramuscular Hemodynamics and Oxygenation After Cold-Spray Application as Monitored by Near-Infrared Spectroscopy.

Authors:  Babak Shadgan; Sports Med; Amir H Pakravan; Alison Hoens; W Darlene Reid
Journal:  J Athl Train       Date:  2015-06-22       Impact factor: 2.860

2.  pFOE or pFTOE as an Early Marker for Impaired Peripheral Microcirculation in Neonates.

Authors:  Nina Hoeller; Christina H Wolfsberger; Daniel Pfurtscheller; Corinna Binder-Heschl; Bernhard Schwaberger; Berndt Urlesberger; Gerhard Pichler
Journal:  Children (Basel)       Date:  2022-06-16

3.  Non-invasively Measured Venous Oxygen Saturation as Early Marker of Impaired Oxygen Delivery in Preterm Neonates.

Authors:  Lukas P Mileder; Julia Buchmayer; Nariae Baik-Schneditz; Bernhard Schwaberger; Nina Höller; Chad C Andersen; Michael J Stark; Gerhard Pichler; Berndt Urlesberger
Journal:  Front Pediatr       Date:  2022-01-28       Impact factor: 3.418

4.  Peripheral fractional oxygen extraction measured with near-infrared spectroscopy in neonates-A systematic qualitative review.

Authors:  Christina H Wolfsberger; Nina Hoeller; Ena Suppan; Bernhard Schwaberger; Berndt Urlesberger; Britt Nakstad; Gerhard Pichler
Journal:  Front Pediatr       Date:  2022-08-23       Impact factor: 3.569

5.  Avoiding Arterial Hypotension in Preterm Neonates (AHIP)-A Single Center Randomised Controlled Study Investigating Simultaneous Near Infrared Spectroscopy Measurements of Cerebral and Peripheral Regional Tissue Oxygenation and Dedicated Interventions.

Authors:  Gerhard Pichler; Nina Höller; Nariae Baik-Schneditz; Bernhard Schwaberger; Lukas Mileder; Jasmin Stadler; Alexander Avian; Jasmin Pansy; Berndt Urlesberger
Journal:  Front Pediatr       Date:  2018-02-01       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.